Product
Gemtuzumab
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid LeukemiaStatus: Not yet recruiting, Estimated PCD: 2028-12-31